🔗 Share this article

A shadow market for unlicensed weight-loss drugs is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these accounts privately for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a flourishing market exists on messaging services, where communities with numerous of participants share comparison images, administration instructions and claims of next-day British shipping. Vendors promote the drug there before directing buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Experts Voice Concerns

However, doctors and chemists have cautions that the sale of what is still an unlicensed drug in the UK is worrisome and could result in users administering substances of uncertain source.

Some professionals stated the popularity for retatrutide could be connected to the rising price of approved slimming products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Some content creators try to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, advertising, and consumer regulations, risking penalties, legal action or imprisonment.

Service Response and Material Removal

According to TikTok, the service has removed problematic content and banned related keywords and query recommendations. The company said it was committed to maintaining the platform secure and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Research also found communities with up to nine thousand participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, glowing testimonials and step-by-step instructions for preparing or administering at home.

Within minutes of entering one community, a vendor posted WhatsApp details, where most purchases occur. The vendor sent an guidebook and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.

Product Information and Pricing

Inside these communities, posts display black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or pre-filled pens usually priced at 160 pounds for 20 milligrams. When questioned how much time a injector should last, sellers give conflicting answers varying between a several days to “depends on your body”.

Platform Moderation and Safety Measures

A spokesperson for the messaging service said it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they cannot confirm. Although the research behind this drug is valid, these digital products may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.

Her staff has already seen patients injured by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company investigational product not yet approved … may expose users to possibly serious medical dangers”.